shah
et
al
better
understand
regulakristen
smith
rinat
yacobi
tion
bcrabl
catalyt
activ
essenti
futur
richard
van
etten
ration
drug
develop
center
blood
research
n
terminu
bcr
contain
region
predict
depart
medicin
form
amphipath
helix
tetramer
pepharvard
medic
school
tide
vitro
mcwhirter
et
al
crystal
structur
boston
massachusett
bcr
coil
coil
recent
solv
zhao
et
al
monom
form
lefthand
helix
character
heptad
repeat
apolar
residu
summari
first
fourth
posit
repeat
two
monom
associ
antiparallel
dimer
stack
bcrabl
dysregul
tyrosin
kinas
whose
form
tetram
consist
experiment
obmechan
activ
unclear
demonserv
delet
initi
amino
acid
bcr
strate
like
cabl
bcrabl
neg
regul
insert
prolinecontain
peptid
domain
kinas
activ
domain
gener
bcrabl
fusion
protein
tion
leukemogenesi
bcrabl
greatli
imdecreas
vivo
tyrosin
kinas
activ
impair
pair
mutat
bcr
coiledcoil
domain
induct
anchorageindepend
growth
fidisrupt
oligomer
restor
point
genesi
depend
oligomer
requir
leubi
analog
receptor
tyrosin
kinas
dikemogenesi
result
suggest
bcrabl
meriz
extracellular
ligand
schlessing
monomer
unphosphoryl
state
simpl
model
suggest
fusion
bcr
activ
domain
engag
intramolecularli
abl
kinas
dimerizationinduc
intermolecular
linker
form
sensit
inhibitor
phosphoryl
fibroblast
transform
bcrabl
imatinib
sole
function
coiledcoil
lack
coiledcoil
domain
restor
redomain
disrupt
autoinhibit
conform
placement
leucin
zipper
domain
oligomer
intermolecular
autopho
mcwhirter
wang
condit
oligomerphoryl
izat
motif
km
rav
unpublish
data
demonstr
transform
properti
bcrintroduct
abl
clarifi
role
bcr
coiledcoil
domain
brasher
et
al
van
etten
et
al
regul
catalyt
oncogen
activ
ntermin
domain
pluk
et
al
regulatori
tyrobcrabl
gener
sever
novel
bcr
coiledcoil
musin
phosphoryl
brasher
van
etten
tation
predict
abrog
oligomer
dorey
et
al
bind
cellular
inhibitor
well
complementari
point
mutat
pendergast
et
al
wen
van
etten
domain
put
bind
site
potenti
autodespit
almost
two
decad
intens
research
phosphoryl
site
abl
examin
abil
mechan
abl
kinas
dysregul
upon
fusion
mutant
form
oligom
vivo
capac
bcr
clearli
understood
recent
small
molecul
transform
fibroblast
hematopoiet
cell
line
inhibitor
abl
kinas
imatinib
mesyl
formerli
profici
induc
leukemia
murin
shown
remark
effect
bone
marrow
retrovir
transductiontransplant
induct
hematolog
cytogenet
remiss
model
cml
cml
patient
kantarjian
et
al
clinic
resist
imatinib
treatment
signific
problem
result
function
domain
bcrabl
protein
depict
includ
left
right
bcr
exon
includ
coiledcoil
cc
oligomer
domain
abl
exon
includ
domain
locat
domain
linker
region
kinas
domain
locat
activ
loop
three
nuclear
local
signal
dna
actin
bind
domain
nuclear
export
signal
locat
bsteii
site
cdna
abl
fusion
protein
found
ph
leukemia
patient
per
domain
murin
coronaviru
spike
protein
abolish
oligomer
biolog
activ
luo
et
al
investig
role
bcr
coiledcoil
domain
regul
catalyt
activ
cellular
transform
leukemogenesi
bcrabl
bcrabl
coiledcoil
domain
mutat
impair
oligomer
vivo
gener
seri
mutat
predict
disrupt
coiledcoil
domain
leav
extrem
bcrabl
predict
form
oligom
coiledcoil
domain
assess
oligomer
n
terminu
bcrabl
intact
remov
amino
acid
delet
entir
coiledcoil
domain
coiledcoil
domain
mutant
gener
addit
construct
truncat
ctermin
bsteii
figur
mutat
phenylalanin
posit
prolin
figur
similar
prolineconsit
figur
fulllength
truncat
tain
peptid
insert
mutant
describ
previous
mutat
place
construct
coexpress
cell
immunoprecipit
antibodi
c
recogn
prolin
middl
domain
predict
disrupt
coiledcoil
introduc
kink
middl
fulllength
protein
figur
lane
antibodi
n
recogn
immunoprecipit
helix
third
mutant
figur
point
mutat
posit
across
fulllength
truncat
protein
figur
lane
strong
coassoci
truncat
protein
coiledcoil
domain
chang
alawa
seen
fulllength
figur
wherea
truncat
longer
associ
fullnin
point
mutat
predict
conserv
helic
structur
coiledcoil
replac
length
version
likewis
coassoci
fulllength
truncat
protein
lost
presenc
residu
essenti
stabil
dimer
structur
similar
alanin
substitut
mutat
leucin
zipof
either
lza
mutat
thu
vivo
oligo
stimul
abl
kinas
activ
brasher
van
etten
surprisingli
vivo
catalyt
activ
rel
unaffect
mutat
meriz
bcrabl
depend
intact
appear
consequ
residu
oligomeramphipath
coiledcoil
domain
izat
mutant
protein
substitut
alanin
coiledcoil
residu
result
low
kinas
activ
figur
decreas
vivo
tyrosin
kinas
activ
bcrabl
coiledcoil
delet
alanin
substitut
compar
result
demonstr
oligomer
requir
dysregmut
restor
loss
function
next
assess
vivo
tyrosin
kinas
activ
ulat
bcrabl
kinas
activ
vivo
previou
studi
demonstr
transform
bcrabl
coiledcoil
mutant
protein
transduc
depend
hematopoiet
cytokinedepend
hematopoiet
cell
line
bcrabl
lack
amino
acid
partial
rescu
cell
bcrabl
retrovirus
select
popul
presenc
prepar
delet
domain
maru
et
al
determin
whether
vivo
tyrosin
kinas
activ
oligoextract
depriv
bcrabl
coiledcoil
mutant
protein
consist
express
level
merizationdefect
bcrabl
restor
loss
ligand
bind
function
gener
two
addihigh
wildtyp
bcrabl
figur
bottom
panel
suggest
oligomer
bcrabl
may
tional
set
bcrabl
mutant
first
set
prolin
mutat
leucin
gener
affect
stabil
protein
vivo
possibl
activ
abl
protein
sensit
figur
mutat
correspond
teasom
degrad
echarri
pendergast
addit
either
mutat
increas
level
cellular
phosphotyrosin
wildtyp
cell
without
grossli
alter
spectrum
phosphoryl
protein
figur
littl
effect
high
constitut
activ
data
demonstr
loss
ligand
bind
function
restor
maxim
vivo
catalyt
activ
bcrabl
absenc
oligomer
determin
impact
oligomer
bcrabl
transform
activ
test
abil
coiledcoil
mutant
induc
anchorageindepend
growth
fibroblast
nih
lza
mutat
also
significantli
reduc
transform
nih
fibroblast
mutant
transform
fibroblast
nearli
effici
wildtyp
mutat
hydrophob
leucin
zipper
residu
alanin
see
figur
abolish
transform
suggest
bcrabl
coiledcoil
delet
alanin
substitut
effect
robust
transform
activ
mutant
defect
transform
primari
thu
point
mutat
abl
domain
putabon
marrow
blymphoid
progenitor
tive
intramolecular
ligand
compens
inactivatto
assess
transform
primari
bone
marrow
ing
mutat
coiledcoil
domain
blymphoid
progenitor
bcrabl
coiledcoil
muto
confirm
point
mutat
affect
tant
freshli
harvest
bone
marrow
transduc
oligomer
coiledcoil
mutant
generwith
bcrabl
retrovirus
plate
whitlock
addit
construct
truncat
witt
condit
bcrabl
stimul
outgrowth
ntermin
bsteii
site
immatur
blymphoid
cell
stroma
depend
fulllength
highli
leukemogen
mice
mclaughlin
et
al
truncat
construct
coexpress
modifi
assay
includ
serial
cell
immunoprecipit
describ
none
dilut
plate
transduc
bone
marrow
doubl
mutant
protein
coaswhich
allow
qualit
assess
transformasoci
vivo
figur
argu
rescu
fibrot
figur
bcrabl
express
result
blast
transform
activ
mutat
due
rapid
outgrowth
cultur
initi
restor
bcrabl
oligomer
cell
condit
figur
cabl
kinas
activ
fulli
follow
sequenti
adher
stromal
cell
seen
cultur
untransautophosphoryl
two
site
activaduc
cell
figur
coiledcoil
delet
alat
loop
catalyt
domain
linker
nine
substitut
mutant
complet
defect
region
catalyt
domain
brasher
assay
detect
growth
even
highest
van
etten
use
tyrosin
phenylalanin
plate
densiti
figur
express
substitut
mutant
examin
requir
result
growth
well
higher
site
bcrabl
kinas
activ
transformapl
densiti
growth
lower
dilut
tion
mutat
either
homolog
activ
loop
impair
rel
wildtyp
figur
tyrosin
linker
tyrosin
doubl
mutant
complet
inact
alon
modestli
decreas
bcrabl
vivo
kinas
activ
figur
transform
three
coiledcoil
doiti
doubl
mutant
display
even
main
mutant
significantli
increas
secondari
lower
activ
figur
tyr
phe
mutat
either
mutat
linker
site
particularli
posit
suffici
abolish
fibroblast
transformabi
mutat
restor
transform
tion
bcrabl
figur
taken
togeth
result
level
wildtyp
case
express
demonstr
loss
either
oligomer
result
modestli
decreas
cell
growth
phosphoryl
result
defect
fibroblast
transforrel
induc
wildtyp
figur
mation
bcrabl
mutant
show
growth
cell
plate
densiti
figur
result
demonstr
oligomer
aubcrabl
coiledcoil
delet
alanin
substitut
tophosphoryl
requir
transform
pri
transform
fibroblast
hematopoiet
cell
line
bcrabl
mutant
correl
well
growth
absenc
figur
like
bcrabl
construct
abl
support
abil
induc
leukemia
vivo
van
etten
emphas
need
assess
role
bcrabl
rapid
growth
contrast
induc
greatli
diminish
prolifer
oligomer
function
autophosphoryl
leukemogenesi
henc
test
abil
condit
follow
addit
hr
cultur
express
reach
bcrabl
coiledcoil
mutant
induc
cmllike
myeloprolif
diseas
mice
use
bone
marrow
retconflu
data
shown
demonstr
oligomer
bcrabl
enhanc
growth
rovir
transductiontransplant
model
assay
mice
transplant
bone
marrow
absolut
requir
transform
cell
agreement
recent
work
figur
character
peripher
blood
leukocytosi
greatli
increas
result
independ
growth
compar
cell
express
wildtyp
phil
hepatosplenomegali
infiltr
spleen
liver
lung
matur
myeloid
cell
li
et
al
figur
fibroblast
loss
bcr
balbc
bone
marrow
transduc
indic
bcrabl
retroviru
plate
indic
cell
number
per
well
triplic
well
nontransduc
cell
ad
total
cell
provid
stromal
support
well
score
posit
viabl
nonadher
cell
number
reach
well
although
previous
report
defect
assay
pendergast
et
al
might
due
low
viru
titer
studi
contrast
mice
transplant
marrow
transduc
antsev
et
al
result
demonstr
effici
oligomer
coiledcoil
domain
fail
develop
cmllike
diseas
instead
succumb
tlymphoid
leukemaxim
level
bcrabl
kinas
activ
requir
induct
cml
mialymphoma
tall
long
latent
period
figur
mutat
rescu
effici
induct
cmllike
diseas
figur
implic
directli
ligand
bind
function
thymu
hemorrhag
malign
pleural
effus
caus
death
figur
disdomain
rescu
mechan
linker
mutat
also
restor
induct
cmllike
eas
induc
bcrabl
point
mutat
domain
impair
catalyt
activ
roumidiseas
although
less
effici
figur
likewis
mutat
either
rehad
myeloprolif
diseas
splenomegali
peripher
blood
leukocytosi
eventu
succumb
store
induct
cmllike
myeloprolif
diseas
figur
mutat
homolog
major
autophosphoryt
figur
mutat
rescu
effect
five
seven
recipi
develop
lation
site
cabl
significantli
attenu
leukemogenesi
bcrabl
major
recipi
cmllike
diseas
remain
two
anim
develop
tall
histiocyt
sarcoma
hs
anoth
marrow
develop
cmllike
diseas
signific
delay
figur
singl
mutat
homolog
cabl
secondari
autophosphoryl
site
linker
interestingli
mutat
also
partial
rescu
induct
myeloprolif
diseas
effect
leukemogenesi
lack
potenti
autophosphoryl
site
three
eight
recipi
develop
typic
cmllike
diseas
one
succumb
simultanewa
sever
impair
induct
cmllike
diseas
major
mice
lack
evid
myeloprolif
cml
ball
remain
mice
cohort
er
diseas
develop
tlymphoma
figur
van
etten
thu
studi
necessari
complet
understand
cabl
precis
mechan
dysregul
cabl
tyroregul
sine
kinas
activ
upon
fusion
bcr
sequenc
given
new
insight
cabl
regul
abl
n
terminu
unclear
despit
intens
studi
like
myeloprolif
diseas
mice
low
deduc
rapid
phosphoryl
may
distect
vivo
tyrosin
kinas
monomer
bcrabl
place
domain
adjac
site
may
reflect
loss
portion
abl
ntermin
cap
result
highli
activ
enzym
activ
equivand
myristoyl
group
mutant
exhibal
cabl
physiolog
activ
ite
signific
vivo
kinas
cell
transform
activcabl
may
involv
autoor
transphosphoryl
iti
like
reflect
residu
oligomer
perhap
src
famili
kinas
plattner
et
al
tect
stringent
coimmunoprecipit
assay
follow
loss
selfinhibit
doubl
mutant
low
kidomain
nase
activ
complet
defect
transforalthough
domain
abl
src
carri
mation
phosphoryl
bcrabl
two
key
regulasimilar
autoinhibitori
function
two
kinas
differ
tori
tyrosin
depend
oligomer
one
import
regulatori
featur
ctermin
phosrequir
leukemogenesi
demonstr
photyrosin
src
famili
kinas
csrc
funccrit
event
induc
bcrabl
oligomer
like
tion
intramolecular
domain
bind
site
intermolecular
autophosphoryl
complet
delet
domain
restor
cell
kinas
activ
cabl
unphosphoryl
inactransform
bcrabl
lack
coiledcoil
dotiv
state
van
etten
et
al
lack
maru
et
al
mechan
involv
ctermin
interact
employ
mechan
also
unknown
demonstr
vivo
kinas
stabil
inact
conform
case
type
activ
cellular
transform
leukemogenesi
ib
cabl
recent
studi
demonstr
sequenc
bcrabl
coiledcoil
delet
alanin
substitut
ntermin
domain
ntermin
cap
mutant
restor
point
mutat
bind
abl
catalyt
domain
pluk
et
al
bcrabl
autoregul
state
similar
cabl
result
provid
direct
proof
hypoth
